The Viral Hepatitis Clinic at Texas Children's Hospital is conducting a randomized, double-blind, placebo-controlled clinical trial for children with Chronic Hepatitis B (CHB). The purpose of this clinical trial is to study the safety and effectiveness of the drug Tenofovir DF in children. If your child is at least 2 years old and less than 12 years old, he or she may be eligible for this study.